Mumbai: Biotechnology firm Biocon on Thursday said its consolidated net profit witnessed nearly three-fold jump at Rs80.8 crore for the third quarter ended 31 December 2009, over the same period previous fiscal.
As per the Indian accounting standards, total income rose to Rs641.5 crore for the quarter ended December, against Rs452.4 crore in the same period last year, Biocon said in a filing to the Bombay Stock Exchange.
“The company has delivered strong growth in all business segments and we are confident of maintaining this momentum in the next quarter,” Biocon chairman and managing director Kiran Mazumdar Shaw said.
On standalone basis, the company has posted a net profit of Rs65 crore for the December quarter, a two-fold jump over the year-ago period.
Shares of Biocon were trading at Rs292.85 on the BSE, up 0.24% from previous close.